The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Podoplanin: emerging functions in development, the immune system, and cancer
Open accessAbstract
Podoplanin (PDPN) is a well-conserved, mucin-type transmembrane protein expressed in multiple tissues during ontogeny and in adult animals, including the brain, heart, kidney, lungs, osteoblasts, and lymphoid organs. Studies of PDPN-deficient mice have demonstrated that this molecule plays a critical role in development of the heart, lungs, and lymphatic system. PDPN is widely used as a marker for lymphatic endothelial cells and fibroblastic reticular cells of lymphoid organs and for lymphatics in the skin and tumor microenvironment. Much of the mechanistic insight into PDPN biology has been gleaned from studies of tumor cells; tumor cells often upregulate PDPN as they undergo epithelial-mesenchymal transition and this upregulation is correlated with increased motility and metastasis. The physiological role of PDPN that has been most studied is its ability to aggregate and activate CLEC-2-expressing platelets, as PDPN is the only known endogenous ligand for CLEC-2. However, more recent studies have revealed that PDPN also plays crucial roles in the biology of immune cells, including T cells and dendritic cells. This review will provide a comprehensive overview of the diverse roles of PDPN in development, immunology, and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“There is a wealth of data on the tumor-promoting effects of CAFs, which has been reviewed elsewhere (Kalluri and Zeisberg, 2006; Gaggioli et al., 2007), but only recently have specific functions for PDPN on CAFs been examined.”
BackgroundOrganizing the cell cortex: the role of ERM proteins
Fehon, R. G., McClatchey, A. I., & Bretscher, A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2866 · Cited by 1,044 · cited 1×
“Phosphorylation causes a conformational change that exposes binding sites for actin and other proteins (Fehon et al., 2010).”
BackgroundStromal Cell Networks Regulate Lymphocyte Entry, Migration, and Territoriality in Lymph Nodes
Bajénoff, M., Egen, J. G., Koo, L. Y., Laugier, J. P., Brau, F., Glaichenhaus, N., & Germain, R. N. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.011 · Cited by 963
Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783 · cited 2×
“TH17 cells are particularly important for the formation of these ectopic germinal centers and EAE progression (Jäger et al., 2009).”
BackgroundShivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693
Tetraspanins: push and pull in suppressing and promoting metastasis
Zöller, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2543 · Cited by 663
T1 /podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
Schacht, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg342 · Cited by 653
Cited by
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Macrophage heterogeneity in tissues: phenotypic diversity and functions
Gordon, S., Plüddemann, A., & Martinez Estrada, F. (2014) · Immunological Reviews · doi:10.1111/imr.12223 · Cited by 715
Activated fibroblasts in cancer: Perspectives and challenges
Caligiuri, G., & Tuveson, D. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.015 · Cited by 424
Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
Barrett, R. L., & Puré, E. (2020) · eLife · doi:10.7554/elife.57243 · Cited by 346
Functional significance of the platelet immune receptors GPVI and CLEC-2
Rayes, J., Watson, S. P., & Nieswandt, B. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122955 · Cited by 328
Xu, X. R., Yousef, G. M., & Ni, H. (2018) · Blood · doi:10.1182/blood-2017-05-743187 · Cited by 325
Astarita, J. L., Cremasco, V., Fu, J., Darnell, M. C., Peck, J. R., Nieves-Bonilla, J. M., Song, K., Kondo, Y., Woodruff, M. C., Gogineni, A., et al. (2015) · Nature Immunology · doi:10.1038/ni.3035 · Cited by 286
Self-citationB cell homeostasis and follicle confines are governed by fibroblastic reticular cells
Cremasco, V., Woodruff, M. C., Onder, L., Cupovic, J., Nieves-Bonilla, J. M., Schildberg, F. A., Chang, J., Cremasco, F., Harvey, C. J., Wucherpfennig, K., et al. (2014) · Nature Immunology · doi:10.1038/ni.2965 · Cited by 276
Self-citationCancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Glabman, R. A., Choyke, P. L., & Sato, N. (2022) · Cancers · doi:10.3390/cancers14163906 · Cited by 254
Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation
Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073868 · Cited by 253
Dionne, K. R., Warnakulasuriya, S., Binti Zain, R., & Cheong, S. C. (2015) · International Journal of Cancer · doi:10.1002/ijc.28754 · Cited by 248
“PDPN is a mucin-type transmembrane glycoprotein with suspected roles in platelet aggregation, actin cytoskeleton reorganization, and cell motility.(99) In a recent study of leukoplakia/erythroplakia, PDPN expression was detected in 89 of 103 (86%) cases and the intensity PDPN immunostaining was correlated to the sever…”
BackgroundA short field guide to fibroblast function in immunity
Buechler, M. B., & Turley, S. J. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2017.11.001 · Cited by 121
Self-citationRuggeri, J. M., Franco-Barraza, J., Sohail, A., Zhang, Y., Long, D., Pasca di Magliano, M., Cukierman, E., Fridman, R., & Crawford, H. C. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.03.020 · Cited by 40
“Furthermore, co-staining for the fibroblastic activation markers podoplanin and a-smooth muscle actin indicated a relative increase in the total number fibroblasts in Ddr1 / animals during recovery after cerulein treatment, possibly explaining the failure of the tissue to fully resolve after injury (Supplemental Figur…”
BackgroundMolecular control of PDPNhi macrophage subset induction by ADAP as a host defense in sepsis
Zhang, P., Wang, X., Yang, X., & Liu, H. (2025) · JCI Insight · doi:10.1172/jci.insight.186456 · Cited by 10
Metadata
- Authors
- Astarita, J. L., Acton, S. E., & Turley, S. J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 283-283
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2156593153
- Cited by
- 402
- References
- 81
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.